Milan, Italy

Pia Furlani

This inventor holds 3 USPTO granted patents. Top assignee: Zambon Group. Active years: 1994-1997.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Pia Furlani. Retrieved from https://idiyas.com/inventor/pia-furlani

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 3

Forward Citations = 157(Granted Patents)


Company Filing History:


Years Active: 1994-1997

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Pia Furlani: Innovator in Pharmaceutical Dosage Forms

Introduction

Pia Furlani is a notable inventor based in Milan, Italy. She has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative dosage forms. With a total of 3 patents to her name, her work is recognized for its impact on drug delivery systems.

Latest Patents

Furlani's latest patents include a programmed release oral solid pharmaceutical dosage form. This invention comprises a core containing the active ingredient, which is coated by a hydrophobic layer. Such dosage forms are designed to release the active ingredient after a pre-established no-release interval, independent of physiological factors. This innovation enhances the effectiveness and reliability of pharmaceutical treatments.

Career Highlights

Pia Furlani is currently associated with Zambon Group, a company known for its commitment to advancing healthcare solutions. Her role at Zambon Group allows her to apply her expertise in pharmaceutical sciences and contribute to the development of cutting-edge products.

Collaborations

Furlani collaborates with her coworker, Franco Pozzi, to further enhance their research and development efforts. Their teamwork exemplifies the importance of collaboration in driving innovation within the pharmaceutical industry.

Conclusion

Pia Furlani's contributions to pharmaceutical dosage forms demonstrate her commitment to improving drug delivery systems. Her innovative patents and collaboration with industry professionals highlight her role as a key figure in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…